Table 1.

Study population baseline characteristics (491 patients)

Patients baseline characteristics
Female gender, n (%)	360/491 (73.3)
Median age, yr (IQR)	35 (30-41)
BMI (kg/m2), n (%) < 18.5 18.5-25 > 25	115 (23.4) 281 (57.2) 95 (19.4)
WHO clinical stage, n (%) 1 or 2 3 or 4	294/491 (60) 197/491 (40)
HIV serology, n (%) HIV-1 HIV-1 and HIV-2	476 (97) 15 (3)
Median CD4+ T-cell count (/mm3) (IQR)	341 (221-470)
CD4+ T-cell < 200/mm3, n (%)	112/491 (22.8)
Median plasma HIV RNA (Log10 copies/mL) (IQR)	4.87 (4.15-5.45)
Plasma HIV-1 RNA > 5 log10 copies/mL, n (%)	221/491 (45)
Serum transaminase level, n (%) AST > UNV	81/491 (16.5)
ALT > UNV	41/491 (8.4)

IQR: Interquartile range; BMI: Body mass index; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; UNV: Upper normal value (50 UI/mL); WHO: World Health Organization; HIV: Human immunodeficiency viruses.